Stephen George Dilly, See Remarks at Aimmune Therapeutics, Inc. (AIMT), sold 102,590 shares at $25.00 ($1.8M) on 2016-11-11, disclosed to the SEC on 2016-11-15.
Open-market sale of $1.8M AIMT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 14,447 | $0 | 0.0% |
| 2 | $0.00 | 14,447 | $0 | 0.0% |
| 3 | $25.00 | 1,304 | $33K | 1.8% |
| 4 | $25.00 | 25,000 | $625K | 33.9% |
| 5 | $25.02 | 23,696 | $593K | 32.2% |
| 6 | $25.02 | 23,696 |
| $593K |
| 32.2% |
| Total | $17.97 avg | 102,590 | $1.8M | 100% |
| Filing → |
| SRRA | BUY | 2021-05-20 | $178K | — | Filing → |
| SGMO | SELL | 2020-03-20 | $210K | — | Filing → |
| SGMO | SELL | 2020-03-18 | $90K | — | Filing → |